Mast cell repopulation of the peritoneal cavity: contribution of mast cell progenitors versus bone marrow derived committed mast cell precursors by Jamur, Maria Célia et al.
Jamur et al. BMC Immunology 2010, 11:32
http://www.biomedcentral.com/1471-2172/11/32
Open Access RESEARCH ARTICLE
© 2010 Jamur et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Research article Mast cell repopulation of the peritoneal cavity: 
contribution of mast cell progenitors versus bone 
marrow derived committed mast cell precursors
Maria Célia Jamur1, Andréa N Moreno1,2, Luciana FC Mello1,2, Devandir A  Souza Júnior1, Maria Rita C Campos1, 
Maria Verônica D Pastor1,3, Ana Cristina G Grodzki1, Deise C Silva3 and Constance Oliver*1
Abstract
Background: Mast cells have recently gained new importance as immunoregulatory cells that are involved in 
numerous pathological processes. One result of these processes is an increase in mast cell numbers at peripheral sites. 
This study was undertaken to determine the mast cell response in the peritoneal cavity and bone marrow during 
repopulation of the peritoneal cavity in rats.
Results: Two mast cell specific antibodies, mAb AA4 and mAb BGD6, were used to distinguish the committed mast cell 
precursor from more mature mast cells. The peritoneal cavity was depleted of mast cells using distilled water. Twelve 
hours after distilled water injection, very immature mast cells could be isolated from the blood and by 48 hours were 
present in the peritoneal cavity. At this same time the percentage of mast cells in mitosis increased fourfold. Mast cell 
depletion of the peritoneal cavity also reduced the total number of mast cells in the bone marrow, but increased the 
number of mast cell committed precursors.
Conclusions: In response to mast cell depletion of the peritoneal cavity, a mast cell progenitor is released into the 
circulation and participates in repopulation of the peritoneal cavity, while the committed mast cell precursor is 
retained in the bone marrow.
Background
Mast cells are known to play a pivotal role in inflamma-
tory and allergic reactions. Recently, they have gained
new importance as immunoregulatory cells with the rec-
ognition that they are a major source of cytokines and
chemokines and play roles in both innate and adaptive
immunity [1-3]. Despite their growing significance in
normal and pathological conditions, much still remains
to be learned about mast cell recruitment and matura-
tion. Like blood cells, mast cells are derived from pluripo-
tent hematopoietic stem cells, but unlike blood cells they
leave the bone marrow as progenitors and migrate to
peripheral sites where they complete their maturation [4-
6]. Mast cell numbers increase at peripheral sites in
response to inflammatory or allergic processes as well as
in response to pathogens [7-9]. This increase in mast cell
number is thought to be the result of proliferation of resi-
dent mast cell progenitors (MCp) as well as the recruit-
ment of MCp from the bone marrow [10-14]. Recent
studies from our laboratory have identified a committed
mast cell precursor (MCcp) present in mouse bone mar-
row that is distinct from the tissue MCp [15]. In the pre-
vious study, a subtractive immunomagnetic isolation
procedure with two mast cell specific antibodies, mAb
AA4 and mAb BGD6, was used to purify the MCcp from
mouse bone marrow. mAb AA4 recognizes two deriva-
tives of the ganglioside GD1b that are unique to rodent
mast cells [15-19], while mAb BGD6 binds to a 110 kDa
protein on the surface of rodent mast cells [15,20]. Both
mAb AA4 [18] and mAb BGD6 bind to granulated mast
cells in all stages of maturation, but mAb BGD6 also
binds to an undifferentiated cell in the bone marrow that
is not recognized by mAb AA4. This undifferentiated cell
was characterized as a MCcp [15]. The present study was
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undertaken to determine the mast cell response in the
peritoneal cavity and the bone marrow during repopula-
tion of the peritoneal cavity in rats. It was of interest to
determine whether the MCp or the MCcp was involved
in repopulation of the peritoneal cavity. The results of the
present study demonstrate that in response to mast cell
depletion of the peritoneal cavity, a MCp is released into
the circulation and migrates to the peritoneal cavity,
while the MCcp is retained in the bone marrow.
Results
Mast cell depletion of the peritoneal cavity reduces the 
mast cell number in bone marrow
Intraperitoneal injection of distilled water is well known
to lyse mast cells resulting in their disappearance [21-28].
In order to examine the kinetics of mast cell repopulation
of the peritoneal cavity following distilled water lysis,
mast cells were immunomagnetically separated from the
peritoneal lavage using either mAb AA4 or mAb BGD6
conjugated to magnetic beads. In non depleted animals
mast cells comprise 25% ± 0.73% of the total cells in the
peritoneal lavage (Fig. 1). These mast cells are replete
with metachromatic granules and are AA4+/BGD6+
[15,18,20]. By 2 days after distilled water injection,
although repopulation of the peritoneal cavity has begun,
the per cent of mast cells in the lavage is only 2.5% ±
0.77% and is composed of very immature mast cells with
characteristics consistent with their identification as
MCp. By light microscopy, these MCp have a large
nucleus and no metachromatic granules (Fig 2A). The
MCp isolated from the peritoneal fluid 48 hours after
injection of distilled water could be conclusively identi-
fied as mast cells only by immunostaining in combination
with transmission electron microscopy. These mast cells
contain a few small cytoplasmic granules, a poorly devel-
oped Golgi complex, few mitochondria and bind IgE (Fig
2B). By immunostaining, more than 98% of these MCp
also express the α subunit of FcεRI, c-kit, CD34 and CD13
and express the mast cell specific gangliosides recognized
by mAb AA4 (Table 1). At six days after distilled water
injection the number of mast cells in the peritoneal lavage
increases to 11.5% ± 1.29% and by ten days the per cent of
mast cells in the peritoneal lavage is close to control val-
ues, 23.75% ± 3.51%. However, there is more variability
among the animals at 10 days, reflecting individual differ-
ences in the rate of mast cell repopulation of the perito-
neal cavity. The mast cells isolated from the peritoneal
lavage six (Fig. 2C) and ten days (Fig. 2D) after distilled
water lysis, are more mature and can be recognized by
light microscopy by the presence of metachromatic gran-
ules. When stimulated by antigen, at 6 days (Fig. 2E) and
10 days (Fig. 2F) after distilled water injection, the mast
cells from the peritoneal cavity degranulate. These imma-
ture mast cells also degranulate in the presence of Com-
pound 48/80 or when FcεRI is crosslinked by mAb BC4
(data not shown), thus demonstrating their functional
capability. By 20 days, repopulation is complete and the
per cent of mast cells is almost the same, 23.3% ± 0.42%,
as in non depleted animals.
If mast cells are being recruited from the bone marrow
to repopulate peripheral sites, then the mast cell number
should be diminished in the bone marrow after mast cell
depletion of the peritoneal cavity. Indeed, repopulation of
the peritoneal cavity by mast cells after distilled water
injection is initially accompanied by a dramatic decrease
in the number of mast cells in the bone marrow (Fig. 3A).
Two days after i.p. injection of distilled water the number
of AA4+/BGD6+ mast cells in the bone marrow has
fallen from 2.42% ± 0.4% to 0.63% ± 0.03%. At six days the
per cent of these mast cells in the bone marrow is recov-
ering and has increased to 0.75% ± 0.01% and by 10 days
has reached 1% ± 0.01%, but does not approach normal
levels until day 20 (2.21 ± 0.37) when mast cell repopula-
tion of the peritoneal cavity is complete. The number of
mast cells is also reduced in a dose dependent fashion 2
days after i.p. injection of Compound 48/80 (Fig. 3B) or
anti-IgE (Fig. 3C), but this reduction is not seen with IgG
(Fig. 3C), indicating that the reduction in mast cell num-
b e r s  i n  t h e  b o n e  m a r r o w  i s  a  g e n e r a l i z e d  r e s p o n s e  t o
mast cell mediator liberation in the peritoneal cavity.
A MCcp, similar to that described for mouse bone mar-
row [15], was also identified in rat bone marrow by
sequential immunomagnetic isolation with magnetic
beads conjugated to mAb AA4 and mAb BGD6. By light
microscopy, the AA4-/BGD6+ mast cells appear as a
homogeneous population of small, 3-4 μm, undifferenti-
Figure 1 Injection of distilled water into the peritoneal cavity re-
sults in a rapid depletion of mast cells . Two days after injection of 
distilled water MCp begin to repopulate the peritoneal cavity and by 
10 days the repopulation is virtually complete. Mast cells were isolated 
from the peritoneal lavage by magnetic beads conjugated to mAb 
AA4. The number of cells free or attached to the magnetic beads was 
determined by counting the cells in a hemocytometer. The average of 
6 independent experiments ± SD is shown.Jamur et al. BMC Immunology 2010, 11:32
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ated cells with a centrally located nucleus?, little cyto-
plasm and contain no metachromatic granules. Electron
microscopy confirmed that the isolated MCcp was a pure
population of small undifferentiated cells containing
scant cytoplasm, few organelles, no cytoplasmic granules
and the cell surface is covered with short microvilli (Fig.
4A). The MCcp comprises 0.02% of the total cell popula-
tion in rat bone marrow. By immunostaining, these cells
are AA4-/BGD6+, c-kit+, CD34+, do not express FcεRI or
bind IgE (Table 1). In contrast to the more mature mast
cells, the per cent of AA4-/BGD6+ MCcp increases sig-
nificantly from 0.02% ± 0.002% to 0.33% ± 0.008% in the
first 48 hours after i. p. injection of distilled water. At six
days, the number of MCcp is 0.26% ± 0.105%, and reaches
0.4% ± 0.117% by 10 days. By 20 days the number of
M C c p  i n  t h e  b o n e  m a r r o w  i s  c l o s e  t o  n o r m a l  v a l u e s
(0.045% ± 0.009%) (Fig. 4B). These results suggest that
MCp are being recruited from the bone marrow to the
peritoneal cavity and that the number of MCcp in the
bone marrow increases in response to the recruitment of
MCp to the peritoneal cavity.
Repopulation of the peritoneal cavity is due to both 
recruitment and proliferation of mast cell progenitors
In order to further investigate the process of repopulation
of the peritoneal cavity, 48 hours after distilled water
injection, the mesenteries were removed and examined
for the presence of mast cells. In non-depleted mesenter-
ies mast cells could be seen along blood vessels and in the
mesenteric windows. These mast cells stained with tolui-
dine Blue (5A) and immunolabeled with either mAb AA4
(5B) or mAb BGD6. In contrast, no mast cells could be
seen in the mesentery of depleted animals by toluidine
blue staining (Fig. 5C). However, when the mesentery was
immunostained with mAb AA4-FITC, MCp could be
seen associated with mesenteric blood vessels (Fig. 5D).
At higher magnification, it is clear that the MCp are
inside the blood vessels (Figs. 5E and 5F). A small number
of MCp, <1 mast cell/106 blood cells, could also be immu-
nomagnetically isolated from circulating blood 12, 24 and
48 hours after mast cell depletion of the peritoneal cavity
(Fig. 6). No mast cells could be isolated from the blood of
non depleted animals. The MCp from the blood are mor-
phologically and phenotypically similar to the MCp
found in the bone marrow [18] as well as to the mature
mast cells in the peritoneal cavity (T able 1). At no time
point could MCcp (AA4-/BGD6+) be isolated from car-
diac blood.
Another factor that may contribute to the increased
number of peritoneal mast cells is the proliferation of
MCp recruited to the peritoneal cavity. In order to inves-
Table 1: Phenotype of MCcp, MCp and Mature Mast Cells (MC)
Bone Marrow  Blood  Peritoneal Cavity 
MCcp MCp* MCp MCp MC
Antibody:
mAb  BGD6  + + + +  + 
mAb AA4  - + + +  + 
Anti-FcεRI  - + + +  + 
Anti-IgE  - + + +  + 
Anti  c-kit  + + + +  + 
Anti-CD13  + + + +  + 
Anti-CD34  +  + ND* + ±
Diameter 3-4 μm  3-6 μm  3-6 μm  3-6 μm  10-20 μm 
*[18]
+ = > 98% of the cells are positive
± = 38% of the cells are positive
- = no immunostaining was detected
Cells were immunostained with the different antibodies in 7 different experiments. In each experiment a minimum of 500 cells per antibody 
were counted by fluorescence microscopy.Jamur et al. BMC Immunology 2010, 11:32
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tigate this possibility, 48 hours after distilled water injec-
tion the peritoneal lavage was collected and
immunostained with both anti-phospho-histone H3 and
mAb AA4. In the animals that had received distilled
water, there was a significant increase in the percentage
of mast cells in mitosis (Fig. 7). These data indicate that it
is a combination of the recruitment of MCp to the perito-
neal cavity as well as the proliferation of these progenitors
that results in mast cell repopulation of the peritoneal
cavity after depletion by distilled water.
Infused mast cell precursors (AA4-/BGD6+) home 
preferentially to the bone marrow
When the peritoneal cavity is depleted of mast cells, the
data presented above suggests that it is the MCp (AA4+/
BGD6+) that is recruited to the peritoneal cavity and that
the MCcp (AA4-/BGD6+) remains and proliferates in the
bone marrow. Therefore, it was of interest to investigate
the homing patterns of the MCcp (AA4-/BGD6+) as well
as the MCp (AA4+/BGD6+). The two populations of
mast cells were immunomagnetically isolated and labeled
with CellTracker™ Red or CellTracker™ Green. The
labeled cells were then infused into the tail vein of rats. At
various time intervals, cells from the bone marrow,
spleen and lungs were examined by FACS for the pres-
ence of the infused cells. At 72 hours after infusion, the
MCcp (AA4-/BGD6+) was concentrated in the bone
marrow, while the MCp (AA4+/BGD6+) was concen-
trated in the spleen. At early times after infusion the MCp
pass through the bone marrow and at 24 hours after infu-
sion both MCcp and MCp are seen to transit through the
lungs (Fig.8). These results confirm that the MCcp (AA4-
/BGD6+) is addressed to the bone marrow.
The behavior of these two mast cell populations was
then investigated during the initial phase of repopulation
of the peritoneal cavity when mast cells are seen in the
blood (Fig. 9). When the peritoneal cavity is not depleted,
no infused cells are observed in the peritoneal lavage. As
expected, under these conditions, the MCp (AA4+/
BGD6+) only pass through the bone marrow, while the
MCcp (AA4-/BGD6+) accumulates there. In contrast,
when the peritoneal cavity is depleted of mast cells by dis-
tilled water both populations of mast cells are seen in the
peritoneal lavage. At 48 hours after distilled water, while
no infused MCp (AA4+/BGD6+) could be found in the
bone marrow, there was a significant accumulation of
MCcp in the bone marrow (Fig. 9). Therefore even under
conditions of mast cell depletion, the infused MCcp still
homes to the bone marrow, while the MCp goes preferen-
tially to the peritoneal cavity.
Discussion
This study demonstrates that bone marrow derived mast
cells are involved in the repopulation of the peritoneal
cavity following mast cell depletion. The MCcp (AA4-/
BGD6+) is retained in the bone marrow and does not cir-
culate, but proliferates and apparently gives rise to MCp
Figure 2 On day 2 following i.p. injection of distilled water only 
MCp are present in the peritoneal lavage . The MCp were isolated 
using magnetic beads conjugated to mAb AA4. (A) By light microsco-
py, the cells, which can be recognized by their attachment to immuno-
magnetic beads (arrows), have a large nucleus and no metachromatic 
granules. Toluidine blue. (B) By electron microscopy the MCp has a 
large centrally located nucleus (N), a few small secretory granules (ar-
rows), and a compact Golgi complex (G). The cell surface also stains 
positively with anti-IgE (arrowheads). IB, immunomagnetic bead; M, 
mitochondria. Immature mast cells are present in the peritoneal lavage 
at 6 and 10 days after distilled water injection. (C) Representative im-
mature peritoneal mast cell 6 days after i.p. injection of distilled water 
contains a few metachromatic granules (arrows). Toluidine blue. (D) 
Peritoneal mast cell, representative of the peritoneal mast cell popula-
tion 10 days after i.p. injection of distilled water, contains many me-
tachromatic granules (arrows). Toluidine blue. (E) Representative 
immature peritoneal mast cell 6 days after i.p. injection of distilled wa-
ter is degranulated after exposure to antigen (arrows, released secreto-
ry granule matrix). Toluidine blue. (F) 10 days after i.p. injection of 
distilled water, this representative peritoneal mast cell, is degranulated 
after exposure to antigen. (arrows, released secretory granule matrix). 
Toluidine blue.Jamur et al. BMC Immunology 2010, 11:32
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that circulate and participate in the repopulation of the
peritoneal cavity.
Mast cells arise in the bone marrow as a committed
p r ecu r s o r  t h a t  l e a v es  t h e  bo n e  m a rr o w  as  a  M C p  a n d
completes its differentiation at peripheral sites [4-6]. The
rat MCcp identified in this study is virtually identical to
the MCcp present in Balb/c mouse bone marrow [15].
The MCcp from both species ranges from 3 μm to 4 μm,
has a large, centrally located nucleus, scant cytoplasm,
and by electron microscopy contain no cytoplasmic gran-
u l e s .  T h e  M C c p  f r o m  b o t h  r a t s  a n d  m i c e  i s  B G D 6 + ,
AA44-, FcεRI-, CD34+, CD13+, c-kit+, and does not bind
IgE. A mast cell (Lin-, c-kit+, Sca-1-, Ly6c-, FcεRIα-,
β7+,T1/ST2+) similar to the MCcp characterized in the
present study has also been identified in bone marrow
from adult C57BL/6 mice. The bone marrow derived
mast cell from C57BL/6 mice gives rise only to mast cells
when cultured and can reconstitute c-kit mutant mast
cell deficient mice [29].
Little is known about the factors that may be responsi-
ble for release of mast cells from the bone marrow and
their recruitment to peripheral sites. In the present study,
two days after mast cell lysis by osmotic shock, degranu-
lation by Compound 48/80 or anti-IgE the number of
mast cells in the bone marrow was the same, indicating
that mediator release by all three methods is equally
effective in reducing mast cell numbers in the bone mar-
row. While mast cell lysis is thought to release only pre-
formed mediators, activation of mast cells by Compound
48/80 or activation through FcεRI releases not only the
pre-formed mediators stored in secretory granules, but
stimulates the immediate production of newly formed
lipid mediators as well as synthesis and release of cytok-
ines and growth factors [30,31]. Weller et al., [32] using
cultured mouse bone marrow mast cells reported that
leukotriene B4, present in supernatants from activated
mast cells, was the factor responsible for migration of
immature mast cells and that other activation products
were ineffective as chemotactic factors. However, since
distilled water causes an immediate lysis of mast cells, it
is not clear which, if any, of the newly-formed mediators
are released. It is more likely that the recruitment of mast
cell progenitors to the peritoneal cavity is mediated by
the pre-formed mediators present in the secretory gran-
ules. A possible candidate for this recruitment is TGFβ1.
Among the cell types involved in an innate immune
response are mast cells [33]. When activated by Com-
pound 48/80, rat mast cells have been shown to liberate
TGFβ1. The TGFβ1 is stored in a latent form in secretory
granules and upon mast cell activation is converted to the
a c t i v e  f o r m  b y  c h ym a s e  1 ,  w h i c h  i s  a l s o  s t o r e d  i n  t h e
secretory granules [34]. Evidence suggests that TGFβ1
may be one of the most potent attractants for mast cells.
TGFβ1 has been shown to cause directed migration of
cultured mouse mast cells at femtomolar concentrations
[35]. In the same study, other known mast cell chemoat-
tractants including laminin, stem cell factor, and IL-3
were all found to be considerably less effective in induc-
ing mast cell migration. In addition to the direct effect of
mediators on mast cells, mast cell recruitment from the
Figure 4 MCcp increase in the bone marrow following mast cell depletion of the peritoneal cavity . MCcp were isolated from bone marrow 
using sequential isolation with mAb AA4 conjugated magnetic beads followed by mAb BGD6 conjugated magnetic beads as detailed in the Materials 
and Methods. (A) By electron microscopy this representative MCcp (AA4-/BGD6+) is a small undifferentiated cell with scant cytoplasm and a large 
nucleus (N). (B) Lysis of peritoneal mast cells results in an increase in the percentage of AA4-/BGD6+ MCcp in the bone marrow. The average of 6 in-
dependent experiments ± SD is shown.Jamur et al. BMC Immunology 2010, 11:32
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bone marrow could also occur through the indirect effect
of mast cell mediators on other cell types [3,36-39], such
as neutrophils, eosinophils, macrophages and fibroblasts.
Activation of these other cell types could stimulate
recruitment of MCp from the bone marrow.
Mast cell repopulation of the peritoneal cavity occurs
not only through recruitment of MCp, but also by prolif-
eration of newly recruited MCp. Under normal, non-
pathological conditions, the mast cell mitotic index is
considered to be very low [40], but in the present study,
48 hours after i.p. injection of distilled water, the percent-
age of mast cells in mitosis was seen to increase four fold.
T h e  u s e  o f  m a s t  c e l l  s p e c i f i c  a n t i b o d i e s  c o u p l e d  w i t h
immunostaining for phospho- histone H3 was essential
Figure 5 Mast cell progenitors are present in mesenteric blood 
vessels 48 hours after IP injection of distilled water . (A) In animals 
not injected with distilled water, mast cells (arrows) can be seen along 
a blood vessel (V) and in the mesenteric windows. (B) The mast cells 
(arrows) are positive when immunolabeled with mAb AA4-FITC (ar-
rows). (C) No mast cells are seen in the mesentery or along a mesenter-
ic blood vessel (V) 48 hours after distilled water injection. Toluidine 
blue. (D) MCp (arrows), detected by mAb AA4-FITC, are associated with 
and inside blood vessels (arrows). (E) Superimposition of MCp in a 
blood vessel immunolabeled with mAb AA4-FITC (arrows) seen in F 
with corresponding DIC image. Other blood cells, which do not label 
with mAbAA4, are also present inside the blood vessel. (F) At this mag-
nification, MCp labelled with mAb AA4-FITC are clearly seen inside a 
mesenteric blood vessel.
Figure 6 MCp could be immunomagnetically isolated from the 
blood after mast cell depletion of the peritoneal cavity . Blood was 
collected by cardiac puncture from nondepleted animals and animals 
whose peritoneal cavity had been depleted of mast cells by distilled 
water. By 12 hours after depletion it was possible to isolate MCps from 
cardiac blood. Only MCps could be isolated from cardiac blood using 
immunomagnetic beads conjugated to mAbBGD6. Mast cells were 
isolated from the blood using magnetic beads conjugated to mAb 
BGD6. The number of cells free or attached to the magnetic beads was 
determined by counting the cells in a hemocytometer. A minimum of 
10 animals were used per time point. Data is expressed as the number 
of mast cells/108 blood cells ± S.D.
Figure 7 Forty eight hours after mast cell depletion of the perito-
neal cavity, there is a greater number of MCp in mitosis . The peri-
toneal lavage was collected from rats depleted or non-depleted of 
mast cells by distilled water injection. The total cell population was 
double immunostained with both anti-phospho-histone H3 and mAb 
AA4 in order to identify mast cells in mitosis. The average of 3 indepen-
dent experiments ± SD is shown.Jamur et al. BMC Immunology 2010, 11:32
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for the identification of dividing MCp that do not yet con-
tain metachromatic granules.
A previous investigation from our laboratory has
shown that while mast cells freshly isolated from rat bone
marrow express the integrin subunits α4, α5, α6, β1 and
β7 on their surface, the more mature, adherent mast cells
expressed significantly more α4 integrin [41]. This
change in expression of α4 integrin may be related to the
release of MCp from the bone marrow to populate
peripheral sites. Specificity of integrin expression is
known to play a pivotal role in mast cell homing. Gurish
et al. [12], have shown that α4β7 integrin, but not αEβ7
integrin is required for tissue specific homing of mast
cells to the small intestine. In β7 deficient C57BL mice,
although mast cells were present in the lung, spleen, bone
marrow and large intestine, mast cells were almost com-
pletely absent from the small intestine. Furthermore, in
Balb/c mice that had been sub-lethally irradiated, admin-
istration of anti-α4β7 integrin, anti-α4 or anti-β7 anti-
bodies blocked the mast cell repopulation of the small
intestine after bone marrow reconstitution.
Conclusions
The present study shows that in response to mast cell
depletion of the peritoneal cavity, it is the MCp that is
released from the bone marrow into the circulation in
order to repopulate peripheral sites. Moreover, the MCcp
is retained in the bone marrow and it is the MCcp popu-
lation that expands to provide additional mast cells to
repopulate these peripheral sites. This increased under-
standing of mast cell recruitment and repopulation pro-
vides additional therapeutic targets for control of the
mast cell population in pathological conditions.
Methods
Animals
Young (150 g) male and female Wistar rats were used.
Animals were housed and experiments were approved
and conducted according to FMRP-USP, Ribeirão Preto,
Brazil guidelines (protocol: 019/2005). For all experi-
ments, animals were sacrificed by CO2 inhalation.
Cells
Bone marrow was removed from the femurs of the rats by
flushing the marrow cavity with Dulbecco's phosphate
buffered saline (PBS) containing heparin (1000 units/mL
(Produtos Roche Químicos e Farmacêuticos S. A., Rio de
Janeiro, R.J., Brazil) 1% BSA (Sigma-Aldrich, St. Louis,
MO) and DNase (1000 U/mL, Type I, Sigma-Aldrich).
The cells were dissociated by aspiration with a Pasteur
pipette, passed through a 25 μm nylon filter and then
rinsed twice by centrifugation (27 × g) in PBS.
Blood was collected by cardiac puncture using a hepa-
rinized syringe.
Peritoneal cells were obtained by injecting rats i.p. with
15 mL PBS. The peritoneal wash was collected following
laparotomy using a Pasteur pipette. The cells were rinsed
twice by centrifugation (27 × g) in PBS and placed on
Cell-Tak™ (BD Biosciences, San Jose, CA) coated cover-
slips.
Antibodies
mAb AA4 (recognizes mast cell specific α-galactosyl
derivatives of the ganglioside GD1b), mAb BGD6 (a mast
cell lineage marker [15,20], and mAb BC4 (binds to the α
subunit of FcεRI) were made in mice against the cell sur-
face of RBL-2H3 cells, a rat mast cell line [16]. An affinity
purified mouse mAb anti- rat IgE was purchased from
Invitrogen, BioSource, Camarillo, CA, and an affinity
Figure 8 MCcp home to the bone marrow . MCcp (AA4-/BGD6+) and MCp (AA4+/BGD6+) were immunomagnetically isolated from the bone mar-
row and labelled with CellTracker Green CMFDA™ or CellTracker Red CMTPX™ respectively. The labelled cells were then infused into the tail vein of 
rats and at various times after infusion bone marrow (A), spleen (B) and lungs (C) were collected. The entire tissue was dissociated and the presence 
of labelled cells analyzed by FACS. The data is expressed as the number of labelled mast cells/105 cells. The average of 3 independent experiments ± 
SD is shown.Jamur et al. BMC Immunology 2010, 11:32
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purified mouse mAb anti- CD34 (ICO115) was pur-
chased from Santa Cruz Biotechnologies, Santa Cruz,
CA. A goat polyclonal antibody against CD13 was pur-
chased from Santa Cruz Biotechnologies. The rabbit
polyclonal antibodies against c-kit (Santa Cruz Biotech-
nologies) and against phospho-histone H3 (anti-phos-
pho-histone H3 (Ser 10) (Millipore, Billerica, MA) were
o b t a i n e d  c o m m e r c i a l l y .  D o n k e y  a n t i - m o u s e  I g G ,  a n t i -
rabbit IgG or anti-goat IgG F(ab')2 fragments conjugated
to FITC or T exas Red® (Jackson ImmunoResearch, West
Grove, PA) were used as secondary antibodies. For elec-
tron microscopy, donkey anti-mouse IgG conjugated to
horseradish peroxidase (Jackson ImmunoResearch) was
used as the secondary antibody. For some experiments
antibodies were directly conjugated to FITC using the
FluoReporter® FITC Protein Labeling Kit or to Texas Red®
using the FluoReporter® Texas Red®-X Protein Labeling
Kit (Invitrogen, Molecular Probes, Camarillo, CA). Con-
trols consisted of omitting the primary antibody or sub-
stituting the primary antibody with IgG from the same
species. All controls were negative.
Depletion and Degranulation of Peritoneal Mast Cells
Animals had their peritoneal cavities depleted of mast
cells by i.p. injection of 15 mL of distilled water. Perito-
neal mast cells were degranulated in vivo by i.p. injection
with 4 mL of compound 48/80 (10-50 μg/mL; Sigma-
Aldrich) in 0.02 M Tyrode-Tris buffer, pH 7.2 [42] or by
i.p. injection of 1 mL containing 1, 2.5, 5, 10 or 15 μg/mL
mAb anti- rat IgE (Invitrogen, BioSource) in PBS. Normal
rat IgG (10 μg/mL, i.p.; Jackson ImmunoResearch Labo-
ratories, West Grove, PA) served as a control.
At 6 and 10 days after distilled water injection, the peri-
toneal lavage was collected in sterile PBS, washed and ali-
quots placed on Cell-Tak™ (BD Biosciences) coated
coverslips. The mast cells were sensitized for 1 hr with
IgE anti-TNP (kindly provided by Reuben Siraganian,
NIDCR, NIH, Bethesda, MD; 1:5000 in HBSS), rinsed in
PBS and stimulated with 50 ng HSA-DNP48  (Sigma-
Figure 9 When the peritoneal cavity is depleted of mast cells, both AA4-/BGD6+ and AA4+/BGD6+ cells go to the peritoneal cavity, but 
only the MCcp (AA4-/BGD6+) home to the bone marrow . MCcp (AA4-/BGD6+) and MCp (AA4+/BGD6+) were immunomagnetically isolated from 
the bone marrow and labelled with CellTracker Green CMFDA™ or CellTracker Red CMTPX™ respectively. The cells were infused into non-depleted 
and depleted rats. At 24 and 48 hours after infusion, the peritoneal lavage and bone marrow were collected and examined by FACS for the presence 
of labelled mast cells. The data is expressed as the number of labelled mast cells/105 cells. The average of 3 independent experiments ± SD is shown.Jamur et al. BMC Immunology 2010, 11:32
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Aldrich) for 30 minutes. In some experiments the mast
cells were stimulated with Compound 48/80 (1 μg/mL;
Sigma-Aldrich ) or mAb BC4 (0.5 μg/mL). After stimula-
t i o n  t h e  c e l l s  w e r e  f i x e d  i n  4 %  f o r m a l d e h y d e  i n  P B S ,
stained with toluidine blue (4% formaldehyde, 0.1% tolui-
dine blue and 1% acetic acid, pH 2.8 for 10 min), and
mounted on glass slides with Permount (Thermo Fisher
Scientific Inc., Waltham, MA). Slides were examined and
images acquired using an Olympus BX-50 microscope
(Olympus America Inc., Melville, NY) coupled to a Nikon
DXM-1200 digital camera (Nikon USA, Melville, NY)
Collection and preparation of mesentery fragments
The duodenum was exposed and fragments of the mes-
entery were carefully detached from the intestine using
surgical scissors. For light microscopy, the mesentery
fragments were placed in a Petri dish, washed 3 times
with PBS, spread over Styrofoam sheet in a Petri dish and
held in place with plastic pins. The fragments were then
fixed in 2% formaldehyde in PBS for 6-7 seconds in a con-
ventional microwave oven [43]. After fixation, the mesen-
tery fragments were washed in distilled water, and spread
on glass slides. Samples to be stained with toluidine blue
were dried on a heating plate at 45°C. After drying, adi-
pose tissue was dissected away.
Cell Separation
mAb BGD6, mAb AA4 or normal mouse IgG (Jackson
ImmunoResearch) were conjugated to tosylactivated
Dynabeads (Invitrogen, Dynal, Camarillo, CA) as previ-
ously described [44]. The cells were isolated according to
the method of Jamur et al. [15]. Immunomagnetic isola-
tion with mAb AA4 was used to obtain pure populations
of granulated mast cells (AA4+/BGD6+) while sequential
isolation with mAb AA4 followed by mAb BGD6 was
u s e d  t o  i s o l a t e  a  p u r e  p o p u l a t i o n  o f  M C c p  ( A A 4 - /
BGD6+).
Cell Counts
Mast cells were isolated with magnetic beads conjugated
with mAb AA4 or mAb BGD6. After isolation, the num-
ber of cells either free or attached to the magnetic beads
was determined by counting the cells in a hemocytome-
ter. One thousand cells/antibody were counted in each of
25 experiments. In order to confirm the results obtained
b y  i m m u n o m a g n e t i c  i s o l a t i o n ,  t h e  p e r c e n t a g e  o f  m a s t
cells that was present in the peritoneal lavage or bone
marrow was determined in a separate set of experiments
by counting the positive and negative cells after immu-
nostaining with mAb BGD6, mAb AA4, or anti-IgE. A
minimum of 1000 cells/antibody was counted in each of
25 experiments. The percentage of metachromatic mast
cells in the peritoneal cavity was also determined by
staining the peritoneal lavage with toluidine blue. All
methods gave identical results.
The percentage of cells positive with mAb BGD6 or
attached to the mAb BGD6 conjugated magnetic beads
was taken as the total mast cell population. The percent-
age of MCcp (AA4-/BGD6+) mast cells was determined
by counting the number of cells from the starting cell sus-
pension that attached to mAb BGD6 beads after clearing
twice with mAb AA4 beads. Five hundred cells attached
to mAb BGD6 beads were counted for each of 41 experi-
ments. The results were confirmed by immunostaining
suspensions of bone marrow cells with both mAb AA4
and mAb BGD6. For cell separation experiments the
number of cells in the peritoneal lavage or total bone
marrow suspension was counted and the number of mast
cells present was calculated based on the percentage of
mast cells in the total bone marrow population as deter-
mined above (2.6 ± 0.5%). The number of MCcp (AA4-/
BGD6+) cells present in the total bone marrow suspen-
sion was also calculated using the percentage (0.02 ±
0.007%) obtained above. The percentage of mast cells
present in the bone marrow was determined by counting
the positive and negative cells after immunostaining with
either mAb AA4 or anti-IgE as well as by counting the
number of cells that were either free or attached to mAb
AA4 conjugated magnetic beads.
Light Microscopy
Cells were rinsed in PBS and placed on coverslips coated
with Cell-Tak™. In some experiments, cells were fixed and
stained with toluidine blue for 10 min or mesentery frag-
ments were fixed and stained with toluidine blue for 15
min. After staining the samples were washed quickly in
distilled water, dehydrated and mounted in Permount
(Thermo Fisher Scientific Inc.). For fluorescence micros-
copy, cells were placed on Cell-Tak™ coated coverslips,
rinsed 3 times in PBS and fixed in 2% formaldehyde in
PBS, or fixed in 2% formaldehyde for 10 minutes and per-
meabilized with Triton X-100 (phospho-histone H3).
Mesentery fragments, fixed as previously described in a
microwave oven, were permeabilized for 5 min in acetone
at -20°C. The cells or mesentery fragments were rinsed in
PBS, PBS containing 0.1 M glycine and incubated with
mAb AA4 (5 μg/mL) or mAb BGD6 (20 μg/mL) directly
conjugated to FITC or to Texas Red®, or anti c-kit (15 μg/
mL), anti-CD13 (20 μg/ml), mAbCD34 (15 μg/ml), anti-
IgE (5 μg/mL), or anti-phospho-histone H3 (5 μg/mL) for
one hour at room temperature. Following incubation, the
cells were rinsed thoroughly in PBS and if needed, the
cells were further incubated with secondary antibody. All
cells were then rinsed and the coverslips mounted with
Fluoromount-G (EM Sciences) and observed by bright
field, fluorescence and DIC microscopy using an Olym-
pus BX-50 microscope (Olympus America Inc.) coupled
to a Nikon DXM-1200 digital camera (Nikon USA,) or byJamur et al. BMC Immunology 2010, 11:32
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scanning confocal microscopy (Leica Microsystems,
Heidelberg, Germany).
Electron Microscopy
For routine electron microscopy, cells were fixed in 2%
glutaraldehyde (Ladd Research Industries, Burlington,
VT) - 2% paraformaldehyde (Ladd) in 0.1 M cacodylate
buffer, pH 7.4, containing 0.05% CaCl2, for 40 min at
room temperature. Because all of the antigens detected
are sensitive to glutaraldehyde, for immuno-electron
microscopy the samples were fixed by microwave. Cells
were suspended in 5 mL of fixative containing 2% formal-
dehyde, 0.05% glutaraldehyde (Ladd Research Industries;
Burlington, VT), 0.025% CaCl2 in 0.1 M cacodylate buffer,
pH 7.4 and irradiated for 4 seconds at 100% power [43].
Immediately after irradiation, 10 mL of PBS was added to
the suspension and the cells were centrifuged for 2 min-
utes (27 × g). The cells were then rinsed twice in PBS, PBS
containing 0.1 M glycine, and then in PBS + 1% BSA.
Cells were incubated with anti- rat IgE (5 μg/mL) diluted
in PBS + 1% BSA for 1 hour at room temperature. After
incubation the cells were rinsed sequentially in PBS + 1%
BSA, PBS, PBS + 1% BSA and then incubated for 1 hour
with donkey anti-mouse IgG conjugated to horseradish
peroxidase (25 μg/mL; Jackson ImmunoResearch) diluted
in PBS + 1% BSA. The cells were then rinsed in PBS + 1%
BSA, PBS and 0.1 M cacodylate buffer (pH 7.4) and
immersed in diaminobenzidine incubation medium (12.5
mL cacodylate buffer, 12.5 mg diaminobenzidine (Poly-
sciences, Inc, Warrington, PA) and 250 μl 1% H2O2) for
30 minutes at room temperature. The cells were then
rinsed 10 times in cacodylate buffer. Some samples were
packed by centrifugation in 1.5% agar before processing
for electron microscopy. Cells were post-fixed in 2%
OsO4 (EM Sciences) for 1 hour at room temperature,
rinsed in distilled water, dehydrated through a graded
series of ethanols, rinsed in acetone and embedded in
Embed 812 (EM Sciences). Thin sections were cut with a
diamond knife and stained for 10 minutes each in Reyn-
olds' lead citrate [45] and uranyl acetate. Cells incubated
without primary antibody or with normal mouse IgG (5
μg/mL; Jackson ImmunoResearch) in place of the pri-
mary antibody served as controls. None of the controls
were immunolabeled.
Proliferation assay
Forty-eight hours after distilled water injection, the peri-
toneal lavage was double stained with anti-phospho-his-
tone H3 (5 μg/mL) to detect proliferating cells and with
mAb AA4 to identify mast cells. A total of 2,500 mast
cells from 10 different fields from 3 separate experiments
were counted.
Homing Assay
MCcp (AA4-/BGD6+) were labelled with CellTracker
Green CMFDA™ (Invitrogen, Molecular Probes) and
more mature mast cells (AA4+/BGD6+) were labelled
with CellTracker Red CMTPX™ (Invitrogen, Molecular
Probes). Cells were incubated for 30 min at 37°C in
Iscove's medium (Invitrogen, GIBCO) with the fluores-
cent cell tracers (25 μg/mL). After incubation, the cells
were rinsed and suspended in Iscove's medium supple-
mented with 10% fetal calf serum and incubated for an
additional 30 min at 37°C. Cell viability, as determined by
trypan blue dye exclusion, was >95%. The labelled cells
(2.5 × 105 in 500 μL PBS) were injected into rats via the
tail vein. The controls animals received only vehicle. In
some experiments, the peritoneal cavity was depleted of
mast cells with distilled water prior to injection of
labelled cells. Tissues were collected from the non-
depleted animals at 1, 6, 24, 48, and 72 hours after cell
infusion and from the animals that had had their perito-
neal cavity depleted of mast cells at 24 and 48 hours after
infusion. The entire bone marrow, spleen, and lung were
dissociated mechanically, the cell suspension homoge-
nized using Pasteur pipettes and rinsed by centrifugation
(27 × g) in PBS. Peritoneal cells were obtained by inject-
ing rats i.p. with 15 mL PBS and collecting the lavage. The
cell suspensions were washed twice by centrifugation (27
× g) in PBS and analyzed by flow cytometry using a BD
FACS Calibur (BD Biosciences; Bedford, MA) with the
CELLQuest program.
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